halothane has been researched along with Hypophosphatasia in 1 studies
Hypophosphatasia: A genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. Clinical manifestations include severe skeletal defects resembling vitamin D-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. (From Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tani, K | 1 |
| Fujii, H | 1 |
| Miwa, S | 1 |
1 other study available for halothane and Hypophosphatasia
| Article | Year |
|---|---|
Changes in erythrocyte glycolytic intermediates during general anesthesia.
Topics: Anesthesia, General; Erythrocytes; Glycolysis; Halothane; Humans; Hypophosphatasia; Sugar Phosphates | 1984 |